Nivolumab vs Telmisartan

## Nivolumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Telmisartan**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Telmisartan**: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Telmisartan — 24 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Telmisartan — C33H30N4O2.

**Molecular Weight**: Nivolumab — N/A; Telmisartan — 514.6230 g/mol.

**Type**: Nivolumab — Antibody; Telmisartan — Small molecule.